and/or its surmises zz top legs affiliates in zztop tickets examines theUnited States and certain other countries. All other trademarks mentioned inthis document are the property of their respective owners. The use of the wordpartner does not imply a partnership relationship between Cisco and any othercompany. This document is Cisco Public Information.SOURCELinksysCisco Press Contact, Karen Sohl, +1-949-823-1578 , ; orIndustry Analyst Contact, Lisa Soto, +1-949-823-4778, ; or,Investor Relations Contact, Matthew Tractenberg, +1-408-525-3170,, all of Cisco. “When The Game Was Ours”Written by: Larry Bird and Earvin Magic Johnson with Jackie MacMullanReviewed by: Joe Gill What can I say about this book? For one, I could not put it down. A book has to grab my attention right away or it finds its way to the Landof Lost Toys AND Books. “When The Game Was Ours” did not find its way to that place. This book brought me back to memories of my youth. As a child of the 80’s, my fondest sports memories were of Celtics-Lakers on Sunday afternoons. Bird McHale The Chief Magic Worthy. Kareem. These are all names that are interwoven into the fabric of my sports soul. To say I was excited to read this book is an understatement! The journey starts with the tandem of Bird and Johnson telling the stories of their childhoods in French Lick and East Lansing.  You learn about their high school playing days and how they were courted by the big time college basketball programs. Bird would choose the powerhouse of Indiana coached by the infamous Bobby Knight and Magic stayed with his hometown school of Michigan State. You will discover the reasons for Bird’s transition from Indiana to dropping out of school and then being wooed by Indiana State.

Bird was very close to cutting his basketball career short. The rivalry between Magic and Bird would start in college culminating with the 1979 NCAA championship. This is when Magic and Bird followed each other’s career obsessively. This is when the rivalry bloomed. This is when the NBA became relevant again. Magic won a championship with the Lakers in 1980 zz top tush . Bird had to win one himself which he did in 1981. Bird and the Celtics would beat the Lakers in the 1984 NBA Finals. Bird finally got even with Magic for his NCAA title game loss. Magic would return the favor in the 1985 NBA Finals. Their competitive fire was burning hotter than ever. Both players had an admiration for the other but had no off court relationship at all. However, that all changed in the fall of 1985. A Converse commercial brought the two together. They would realize they had a lot in common. They became friends and kindred spirits. Magic and Bird would meet again in the Finals in 1987.  Magic’s Lakers would come out on top again. However, their friendship would continue to grow. Larry was there for Magic when he was diagnosed with HIV in November 7, 1991, which generated a league wide scare. You will also read about the strain of the friendship between Magic and Isiah Thomas sharp dressed man mp3 . It would be a relationship that started to deteriorate after Thomas’ racial comments about Larry Bird and then his questioning of Magic’s sexuality. You will also get inside information and stories from the 1992 Olympics and the Dream Team A new rivalry between Magic and Jordan would be formed Bird and Jordan would become close friends at the same time frank beard . And Isiah Thomas would be left off the roster for a variety of reasons. These are just some of the stories and moments you will learn about Earvin “Magic” Johnson and Larry Bird in their own words. You do not have to love the Celtics or Lakers This is a must read for any basketball or sports fan zztop deguello . If you want to learn how the game was saved and rejuvenated, pick up “When The Game Was Ours.” Joe Gill is a featured blogger for Boston Sports Then and Now, Rootzoo and Trufan . Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials ofPicoplatin in Colorectal and Prostate CancersPosters at the American Society of Clinical Oncology (ASCO) SymposiaSOUTH SAN FRANCISCO, Calif., Jan 7 /PRNewswire-FirstCall/ — PoniardPharmaceuticals, Inc.

(Nasdaq: PARD), a biopharmaceutical company focused oninnovative oncology therapies, today announced that the Company will presentdata from two ongoing Phase 2 clinical trials of picoplatin at two upcomingAmerican Society of Clinical Oncology (ASCO) Symposia.In January, the Company will present updated data from its Phase 2 trialof picoplatin in patients with metastatic colorectal cancer at ASCO’s 2009Gastrointestinal (GI) Cancers Symposium in San Francisco.In February,updated data from the ongoing Phase 2 trial of picoplatin in patients withmetastatic hormone refractory (or castration resistant) prostate cancer willbe presented at ASCO’s Genitourinary (GU) Cancers Symposium in Orlando, Fla.Presentation details are as follows:–The ASCO 2009 GI Cancers Symposium, San Francisco–Randomized Phase 2 study of picoplatin in combination with5-fluorouracil and leucovorin (FOLPI) as a neuropathy-sparingalternative to mFOLFOX-6 as first-line therapy for colorectalcancer (CRC)–R H Earhart, S V Cheporov, O A Gladkov, M Y Biakhov, G S.Baker, H B . Breitz–Saturday, January 17, 12:30-1:30–The ASCO 2009 GU Cancers Symposium, Orlando, Fla.–Results of a Phase 2 study of picoplatin with docetaxel andprednisone in first-line treatment of metastatic hormonerefractory prostate cancer (HRPC)–R Earhart, L Roman, N Lopatkin, P Karlov,H Breitz, DavidKarlin, R zztop lagrange . De Jager–Friday, February 27, 11:45-1:15About Poniard PharmaceuticalsPoniard Pharmaceuticals, Inc zztop eliminator . is a biopharmaceutical company focused onthe development and commercialization of innovative oncology products toimpact the lives of people with cancer . Picoplatin, the Company’s leadplatform product candidate, is a new generation platinum therapy with animproved safety profile relative to existing platinum-based cancer therapies.Picoplatin is designed to overcome platinum resistance associated withchemotherapy in solid tumors, and is being studied in multiple cancerindications, combinations and formulations. Clinical trials of intravenouspicoplatin include a Phase 3 trial in small cell lung cancer and Phase 2trials in metastatic colorectal and hormone-refractory prostate cancers, aswell as a clinical trial of oral picoplatin in solid tumors. Picoplatin hasnot been approved by any regulatory authority for use in humans.